Cargando…
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes
The differences in genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma remain unclear. We developed a customized, targeted gene sequencing panel for efficient and sensitive identification of germline variants, including whole-gene deletion types for cancer-related drug-metaboli...
Autores principales: | Ohnami, Sumiko, Naruoka, Akane, Isaka, Mitsuhiro, Mizuguchi, Maki, Nakatani, Sou, Kamada, Fukumi, Shimoda, Yuji, Sakai, Ai, Ohshima, Keiichi, Hatakeyama, Keiichi, Maruyama, Kouji, Ohde, Yasuhisa, Kenmotsu, Hirotsugu, Takahashi, Toshiaki, Akiyama, Yasuto, Nagashima, Takeshi, Urakami, Kenichi, Ohnami, Shumpei, Yamaguchi, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606290/ https://www.ncbi.nlm.nih.gov/pubmed/36289279 http://dx.doi.org/10.1038/s41598-022-22914-6 |
Ejemplares similares
-
BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer
por: Ohnami, Shumpei, et al.
Publicado: (2021) -
JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing
por: Serizawa, Masakuni, et al.
Publicado: (2021) -
Mutational concordance analysis provides supportive information for double cancer diagnosis
por: Hatakeyama, Keiichi, et al.
Publicado: (2021) -
Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy
por: Hatakeyama, Keiichi, et al.
Publicado: (2019) -
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients
por: Hatakeyama, Keiichi, et al.
Publicado: (2020)